Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suxin Tongqiao Granules for Persistent Allergic Rhinitis (Phase III)
CTR20233720Phase 3Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Nov 2023
- Countries
- 1
01
Overview
A Phase 3 trial of Zixin Biqiu Granules in allergic rhinitis (AR), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
Zixin Biqiu Granules
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20233720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233720.